Global Ganja Report

Voters in Arizona, Mississippi, Montana, New Jersey, Oregon and South Dakota passed statewide ballot measures favoring medical marijuana, adult-use cannabis legalization or hemp cultivation in the Nov. 3 elections.

Can Rural America's Expropriated Use a New Crop to Forge a New Agrarianism?

Green Heffa Farms, in North Carolina’s Piedmont, has emerged as a national symbol of vision and success in America’s new hemp economy. As a producer of boutique full-spectrum hemp-flower products, it has won a cachet in the industry—which is augmented, at least in more enlightened sectors, by the fact that it is Black-owned, and has an overt political consciousness.

Green Heffa’s CEO is Clarenda Stanley—popularly known as Farmer Cee. She was featured in the April issue of Oprah Winfrey’s O Magazine, and was last year the 2019 “Featured Farmer” for National Hemp History Week.

Amid a bloody prison uprising in Mississippi, hip-hop superstar Jay Z has launched suit against state authorities on behalf of inmates at the violence-plagued penitentiary. Mississippi has some of the harshest cannabis laws in the country, and pot convictions are big factor contributing to the dire crisis of overcrowding and brutality in the state's lock-ups.

A new law in Georgia will allow the production of cannabis for medical purposes. The measure gives teeth to a formalistic 2015 law that legalized patient use of low-THC cannabis oil, but still inhibited actual access. Now the Peach State is poised to develop a cannabis business sector.

With passage of the Farm Bill and removal of hemp-derived CBD from controlled substance status, big market growth is expected for the very chic and purportedly salubrious non-psychoactive cannabinoid. The law is a win for a nascent CBD industry that has been struggling to shake off the lingering stigma surrounding (psychoactive) cannabis. The effort to segment cannabidiol from "marijuana" is exemplified in the several states that now have "CBD-only" laws.

With general legalization in Oregon, the number of people enrolled in the state medical marijuana program is plummeting, and there is talk of actually ending it. Authorities have already dramatically slashed the limit for daily sales, supposedly in a crackdown on diversion to the black market—which continues to thrive, even amid the notorious over-supply.

Cannabis has become a global industry, but obviously it is still limited by legal restrictions—and the fact that these increasingly vary from country to country further complicates things. Where is commercial cannabis going and where is it coming from? And how is this likely to change as the international atmosphere further liberalizes?

After much speculation that the US Drug Enforcement Agency (DEA) would reschedule cannabis this summer, the agency on Aug. 11 dashed petitioners' hopes, rejecting their request to remove its classification as a Schedule I dangerous drug. The DEA denied two separate requests by former state governors to re-classify cannabis as a Schedule II drug or lower. The agency stated (PDF) that the Department of Health and Human Services (HHS) has "concluded that marijuana has high potential for abuse, has no accepted medical use in the United States, and lacks an acceptable level of safety for use even under medical supervision." Tthe DEA did propose a new policy that would allow universities to apply to grow cannabis for research. Until now, the University of Mississippi had a monopoly on cultivation for study. (Jurist)